Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
000050 Tianma Microelectronics
- 8.25
- +0.06+0.73%
Not Open Apr 1 15:00 CST
20.28BMarket Cap-30.33P/E (TTM)
8.33High8.18Low107.01KlotVolume8.20Open8.19Pre Close88.26MTurnover0.44%Turnover RatioLossP/E (Static)2.46BShares10.5652wk High0.74P/B20.28BFloat Cap6.0652wk Low9.01Limit Up2.46BShs Float36.72Historical High7.37Limit Down1.83%Amplitude-0.13Historical Low--Dividend TTM8.25Avg Price47.39KlotAsk--Div YieldTTM100Lot Size57.37KlotBid
Tianma Microelectronics Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.79%33.49B | -2.78%24.01B | -0.66%15.9B | 0.54%7.75B | 2.62%32.27B | 2.01%24.7B | 1.68%16B | -11.15%7.71B | -6.87%31.45B | -4.49%24.21B |
| Operating revenue | 3.79%33.49B | -2.78%24.01B | -0.66%15.9B | 0.54%7.75B | 2.62%32.27B | 2.01%24.7B | 1.68%16B | -11.15%7.71B | -6.87%31.45B | -4.49%24.21B |
| Other operating revenue | 10.41%302.58M | ---- | -64.80%118.17M | ---- | -41.39%274.05M | ---- | 39.97%335.69M | ---- | -8.14%467.59M | ---- |
| Total operating cost | -2.32%34.6B | -8.23%24.83B | -5.76%16.6B | -4.31%8.19B | 9.66%35.42B | 10.88%27.05B | 11.20%17.61B | -1.48%8.55B | -4.53%32.3B | -2.58%24.4B |
| Operating cost | -3.45%29.05B | -10.95%20.81B | -7.12%14.02B | -5.04%6.88B | 9.84%30.08B | 11.80%23.37B | 12.17%15.1B | -2.98%7.25B | -7.70%27.39B | -5.30%20.9B |
| Operating tax surcharges | 1.51%213.7M | -7.42%142.1M | -15.11%88.55M | -32.86%46.15M | 8.10%210.53M | 21.17%153.48M | 21.08%104.31M | 33.76%68.74M | -18.80%194.75M | -20.87%126.67M |
| Operating expense | 2.38%391.37M | 0.67%284.4M | -2.34%187.17M | -1.69%88.68M | -8.94%382.27M | 2.37%282.51M | 8.65%191.65M | 4.83%90.21M | 23.43%419.8M | 11.23%275.96M |
| Administration expense | 1.65%859.54M | 1.59%615.01M | 1.76%358.76M | -2.52%203.93M | -22.79%845.57M | -22.55%605.36M | -12.35%352.56M | -14.00%209.2M | 8.37%1.1B | 18.13%781.63M |
| Financial expense | 0.75%839.95M | 13.30%664.94M | -1.80%398.15M | 1.21%211.34M | 78.99%833.71M | 125.16%586.86M | 74.69%405.46M | 13.93%208.82M | -17.76%465.8M | -37.54%260.65M |
| -Interest expense (Financial expense) | -0.95%1.04B | 3.00%797.24M | 8.96%544.84M | 20.55%282.41M | 18.11%1.05B | 17.12%774.06M | 16.88%500.05M | 15.03%234.27M | 50.14%892.27M | 42.73%660.91M |
| -Interest Income (Financial expense) | 45.81%-103.13M | 37.93%-86.34M | 26.86%-60.51M | 18.32%-35.48M | -39.09%-190.32M | -94.46%-139.11M | -479.01%-82.73M | -1,476.76%-43.44M | -902.09%-136.83M | -625.87%-71.54M |
| Research and development | 6.00%3.25B | 12.33%2.31B | 5.68%1.54B | 3.29%751.97M | 12.08%3.06B | 0.25%2.06B | -1.43%1.46B | 12.47%728.03M | 36.73%2.73B | 38.00%2.05B |
| Credit Impairment Loss | -63.89%-23.99M | 73.91%-4.1M | 15.39%-12.1M | 187.92%1.92M | -1,032.52%-14.64M | -79.83%-15.72M | -201.26%-14.3M | 70.13%-2.19M | -85.21%1.57M | -0.22%-8.74M |
| Asset Impairment Loss | -2.26%-534.66M | 2.89%-349.78M | -3.06%-235.65M | -30.29%-123.28M | -17.85%-522.85M | -4.27%-360.18M | 7.00%-228.66M | 8.89%-94.62M | 47.21%-443.67M | 41.66%-345.42M |
| Other net revenue | -46.53%652.95M | -38.95%378.64M | 26.56%259.84M | -2.10%136.35M | 24.69%1.22B | 17.65%620.18M | -50.53%205.31M | 46.99%139.29M | 873.49%979.43M | 1,046.77%527.15M |
| Invest income | 31.73%-240.03M | 26.09%-188.65M | 26.60%-108.02M | 6.03%-45.77M | -278.89%-351.61M | -649.20%-255.26M | -1,026.47%-147.17M | -951.95%-48.71M | -856.99%-92.8M | -356.06%-34.07M |
| -Including: Investment income associates | 31.50%-239.05M | 25.72%-187.67M | 26.72%-107.03M | 7.31%-45.15M | -277.97%-348.98M | -641.50%-252.63M | -1,017.90%-146.05M | -951.95%-48.71M | -914.79%-92.33M | -352.49%-34.07M |
| Asset deal income | -99.46%2.53M | -99.39%2.56M | -83.74%2.64M | -99.41%29.46K | 388.12%464.43M | 2,367.09%420.41M | 18,392.69%16.25M | 15,349.54%4.97M | 1,644.00%95.15M | 4,950.44%17.04M |
| Other revenue | -11.96%1.45B | 10.55%918.62M | 5.83%612.97M | 8.44%303.45M | 15.98%1.65B | -7.50%830.92M | -12.23%579.18M | 32.88%279.83M | 100.62%1.42B | 37.39%898.34M |
| Operating profit | 76.69%-449.03M | 74.95%-434.03M | 68.62%-440.23M | 57.54%-300.25M | -1,592.77%-1.93B | -604.61%-1.73B | -543.67%-1.4B | -915.71%-707.16M | 166.87%129.03M | -3.07%343.32M |
| Add:Non operating Income | -50.98%8.82M | -94.08%3.36M | -89.88%1.91M | -71.70%1.66M | -56.27%17.99M | 38.25%56.85M | -20.07%18.91M | -16.22%5.86M | -2.15%41.15M | 7.20%41.12M |
| Less:Non operating expense | -45.21%12.84M | -65.68%7.09M | -0.14%6.11M | 33.61%5.52M | 290.87%23.44M | 411.42%20.67M | 226.62%6.12M | 243.50%4.13M | 53.70%6M | 108.54%4.04M |
| Total profit | 76.55%-453.05M | 74.19%-437.76M | 68.03%-444.42M | 56.89%-304.11M | -1,276.46%-1.93B | -545.90%-1.7B | -511.29%-1.39B | -862.73%-705.43M | 206.07%164.19M | -2.61%380.41M |
| Less:Income tax cost | 33.68%238.35M | -62.74%38.13M | 29.23%47.59M | 99.61%-167.91K | 211.57%178.3M | 407.80%102.33M | 211.56%36.82M | -424.37%-43.5M | 147.53%57.23M | 117.25%20.15M |
| Net profit | 67.23%-691.4M | 73.54%-475.89M | 65.52%-492.01M | 54.08%-303.94M | -2,072.55%-2.11B | -599.25%-1.8B | -484.62%-1.43B | -937.07%-661.93M | 411.04%106.96M | -29.00%360.25M |
| Net profit from continuing operation | 67.23%-691.4M | 73.54%-475.89M | 65.52%-492.01M | 54.08%-303.94M | -2,072.55%-2.11B | -599.25%-1.8B | -484.62%-1.43B | -937.07%-661.93M | 411.04%106.96M | -29.00%360.25M |
| Less:Minority Profit | -84.93%-22.82M | 61.03%-3.27M | 4.89%-2.62M | -1,047.27%-3.2M | -161.09%-12.34M | -6,294.88%-8.39M | ---2.75M | --337.36K | ---4.73M | ---131.18K |
| Net profit of parent company owners | 68.13%-668.58M | 73.60%-472.62M | 65.64%-489.39M | 54.59%-300.75M | -1,978.03%-2.1B | -596.74%-1.79B | -483.88%-1.42B | -937.50%-662.27M | 424.78%111.69M | -28.98%360.39M |
| Earning per share | ||||||||||
| Basic earning per share | 68.13%-0.272 | 73.60%-0.1923 | 65.64%-0.1991 | 54.58%-0.1224 | -1,979.96%-0.8535 | -596.86%-0.7284 | -483.77%-0.5795 | -936.96%-0.2695 | 424.29%0.0454 | -29.01%0.1466 |
| Diluted earning per share | 68.13%-0.272 | 73.60%-0.1923 | 65.64%-0.1991 | 54.58%-0.1224 | -1,979.96%-0.8535 | -596.86%-0.7284 | -483.77%-0.5795 | -936.96%-0.2695 | 424.29%0.0454 | -29.01%0.1466 |
| Other composite income | -486.62%-39.65M | 54.66%-14.86M | -293.52%-51.98M | -7.03%-29.21M | -156.58%-6.76M | -26.03%-32.78M | 62.85%-13.21M | 6.93%-27.3M | 118.06%11.95M | 41.44%-26.01M |
| Other composite income of parent company owners | -486.62%-39.65M | 54.66%-14.86M | -293.52%-51.98M | -7.03%-29.21M | -156.58%-6.76M | -26.03%-32.78M | 62.85%-13.21M | 6.93%-27.3M | 118.06%11.95M | 41.44%-26.01M |
| Total composite income | 65.46%-731.05M | 73.20%-490.75M | 62.23%-544M | 51.66%-333.16M | -1,880.06%-2.12B | -647.91%-1.83B | -529.33%-1.44B | -1,485.41%-689.23M | 218.29%118.91M | -27.81%334.24M |
| Total composite income of parent company owners | 66.34%-708.23M | 73.26%-487.48M | 62.34%-541.38M | 52.15%-329.96M | -1,802.03%-2.1B | -645.19%-1.82B | -528.51%-1.44B | -1,486.09%-689.56M | 222.99%123.64M | -27.78%334.37M |
| Total composite income of minority owners | -84.93%-22.82M | 61.03%-3.27M | 4.89%-2.62M | -1,047.27%-3.2M | -161.09%-12.34M | -6,294.88%-8.39M | ---2.75M | --337.36K | ---4.73M | ---131.18K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.